CITIC Capital Acquires China’s Guilong Pharmaceutical
Source(s): Citic Capital
Trustar Capital, the private equity affiliate of CITIC Capital, acquired Guilong Pharmaceutical, a China-based OTC medicine manufacturer for sore throats.
Source(s): Citic Capital
Trustar Capital, the private equity affiliate of CITIC Capital, acquired Guilong Pharmaceutical, a China-based OTC medicine manufacturer for sore throats.